HDAC9 and glioblastoma: In addition, curcumin has been proven to inhibit cell proliferation, invasion, angiogenesis, and metastasis of GBM in our previous work; thus, we hypothesis that curcumin could be developed as an HDAC inhibitor for the treatment of GBM (24–26).